A letter from Elanco - Seresto Collar Concerns

Dear Valued Customer,

• Seresto remains available to consumers across the U.S. and around the world for protection of pets from fleas and ticks, which can negatively impact their quality of life and, further, may act as vectors of dangerous disease. There is no recall of Seresto products, nor has one been asked for or suggested by any regulatory agency.
• Elanco continues to stand behind the safety profile of Seresto and there is no established link between death and exposure to the active ingredients contained in Seresto.
• As a globally marketed product, more than 80 regulatory authorities around the world, including the US EPA, rigorously reviewed the safety data collected over the course of Seresto’s development prior to registration and/or approval, as appropriate. The safety and efficacy of Seresto are continuously monitored by regulatory bodies globally as well as via internal processes.
• Since its initial U.S. registration in 2012, more than 25 million Seresto collars have protected dogs and cats from fleas and ticks that can transmit disease and that can impact their quality of life.
• All adverse events, product related or not, are collected, evaluated and reported. It is critically important to understand that a report is not an indication of cause.
• Since its approval, the reporting rate for U.S. incidents related to Seresto is less than 0.3%. The significant majority of these incidents relate to non-serious effects, such as dermatologic application site issues. It is important to make sure the collar is not fitted too tightly around the animal’s neck. We recommend the collar be snug while still being able to fit 2 to 3 fingers under it.
• It is important that consumers purchase collars from an authorized clinic or retailer to ensure the authenticity and integrity of the products they are buying.